Anti-CYP2C9 Antibody

This rabbit polyclonal antibody targets CYP2C9, a major cytochrome P450 family 2 subfamily C member that participates in hepatic phase I drug metabolism and handles clinically important substrates including the anticoagulant warfarin, the anticonvulsant phenytoin, and several non-steroidal anti-inflammatory drugs. Produced in rabbit and supplied as an unconjugated reagent at 1 mg/ml in phosphate buffered saline (PBS) with 0.05% sodium azide at approximately pH 7.2, it is packaged in a 100 µl vial and is validated for Western blot detection across human, mouse, and rat samples. Researchers studying pharmacogenomics, xenobiotic clearance, drug-drug interaction screens, and hepatic enzyme regulation use this reagent to probe CYP2C9 protein expression in tissue lysates and cell line extracts, and the polyclonal format provides broader epitope coverage useful when surveying isoforms or following expression changes after induction or inhibition studies. For best results, aliquot on first use and store refrigerated; the included sodium azide serves as a microbial preservative. Antibodies.com supplies this primary antibody as part of its cytochrome P450 reagent portfolio, supporting routine immunoblotting workflows in academic and pharmaceutical research laboratories.